Previous close | 77.65 |
Open | 77.65 |
Bid | 77.75 x 1000 |
Ask | 77.79 x 800 |
Day's range | 77.60 - 78.28 |
52-week range | 60.83 - 81.42 |
Volume | |
Avg. volume | 3,211,551 |
Market cap | 41.767B |
Beta (5Y monthly) | 0.41 |
PE ratio (TTM) | 15.44 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Pediatrix's (MD) Q1 results benefit from higher same-unit revenues, resulting from growing patient volumes, partly offset by high costs. It continues to expect 2024 adjusted EBITDA within $200-$220 million.
Select Medical (SEM) revises its adjusted EBITDA guidance upward between $845 million and $885 million for 2024, the mid-point is higher than $807.4 million in 2023.
Acadia Healthcare's (ACHC) Q1 results aided by improved revenue per patient day, partly offset by escalating costs. It continues to expect 2024 adjusted EPS within $3.40-$3.70.